As the world adapts to a post-pandemic reality, a new COVID-19 variant emerging in 2025 has sparked renewed concern across global health systems. Despite major advances in vaccination, therapeutics, and public health preparedness, the recent appearance of a novel SARS-CoV-2…
The idea of booster doses for Covid-19 vaccinations is gaining traction around the world, but India remains a skeptic. Various countries, including the United States and Israel, have approved these doses. Despite a global lack of vaccines, they were implemented…
The COVID-19 pandemic has transformed the worldwide regulator performing on approval of medicine as a fast-track process and involved in mutual accord in bringing a drug of importance for the civic. This is a major challenge as the safety and…
The COVID-19 pandemic has transformed the worldwide regulator performing on approval of medicine as a fast-track process and involved in mutual accord in bringing a drug of importance for the civic. This is a major challenge as the safety and…
According to WHO, there are 42 vaccine candidates that have reached various phases of the clinical stage of development. “The vaccine is coming soon” is what the general mindset is. The question, however, we are facing currently in these worldwide…
The world is now several months into the “Coronavirus disease (COVID-19)” global pandemic caused by the SARS-CoV-2 virus. As lockdown restrictions slowly begin to lift in certain regions, the pursuit for a safe and effective vaccine against the virus continues…
– Public Health Emergency The Central Drugs Standard Control Organization (CDSCO) acknowledges the potential impact of COVID-19 pandemic on the healthcare system and broader society, and the impact it may have on clinical trials and subjects. The present situation across…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.